SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $64,000 | +30.6% | 690 | +9.5% | 0.01% | +33.3% |
| Q2 2021 | $49,000 | -15.5% | 630 | -19.2% | 0.01% | -33.3% |
| Q1 2021 | $58,000 | -32.6% | 780 | +54.2% | 0.01% | -35.7% |
| Q4 2020 | $86,000 | +21.1% | 506 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $71,000 | -37.2% | 506 | -28.3% | 0.01% | -42.9% |
| Q2 2020 | $113,000 | +63.8% | 706 | 0.0% | 0.02% | +40.0% |
| Q1 2020 | $69,000 | -23.3% | 706 | +0.9% | 0.02% | -6.2% |
| Q4 2019 | $90,000 | +500.0% | 700 | +250.0% | 0.02% | +433.3% |
| Q3 2019 | $15,000 | -50.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $30,000 | +25.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $24,000 | +9.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $22,000 | -72.8% | 200 | -60.0% | 0.01% | -72.7% |
| Q3 2018 | $81,000 | +22.7% | 500 | 0.0% | 0.02% | +15.8% |
| Q2 2018 | $66,000 | +266.7% | 500 | +66.7% | 0.02% | +111.1% |
| Q3 2016 | $18,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |